Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Zhihui Bai

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 4

  1. N6-Methylandenosine-related lncRNAs as potential biomarkers for predicting prognosis and the immunotherapy response in pancreatic cancer. Co-author DOI 10.1007/s00018-024-05573-w↗
  2. Circular RNA LIPH promotes pancreatic cancer glycolysis and progression through sponge miR-769-3p and interaction with GOLM1. Co-author DOI 10.1002/ctm2.70003↗
  3. Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of disease. Co-author DOI 10.1186/s12885-024-12755-z↗
  4. Identification of prognostic immune-related lncRNAs in pancreatic cancer. Co-author DOI 10.3389/fimmu.2022.1005695↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaomeng He · 4 shared papers, 2022–2025 · strength 0.79
  2. Jin Wang · 3 shared papers, 2022–2025 · strength 0.58
  3. Jin Wang · 1 shared paper, 2024 · strength 0.21
  4. Li Xu · 1 shared paper, 2024 · strength 0.19
  5. Yan Ma · 1 shared paper, 2024 · strength 0.19
  6. Yan Ma · 1 shared paper, 2022 · strength 0.16
  7. Shanshan Liu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.